Melanocytic marker Melan-A detects molluscum contagiosum bodies
Melan-A is one of the most commonly used immunohistochemical assays (IHC) in dermatopathology laboratories to detect the presence and outline the distribution of melanocytes. It is a cytoplasmic stain that detects a melanocyte-specific cytoplasmic protein involved in the formation of stage II melanosomes. Clinically, Melan-A is primarily used to detect and confirm melanocytic tumors although it is also positively expressed in adrenal cortical tumors and sex cord stromal tumors. We found that Melan-A also detected and highlighted Henderson-Patterson bodies of molluscum poxvirus. To determine if other melanocytic markers detect molluscum contagiosum bodies, S-100, HMB-45, MITF, and SOX-10 were also tested. In 15 tested molluscum cases, Melan-A stains were positive in all cases, whereas the other tested melanocytic markers were negative. Our results confirm that Melan-A is very sensitive in detecting molluscum contagiosum bodies and could be clinically useful to supplement the hematoxylin and eosin (H&E) in cases that are very inflamed or only have limited biopsy material.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
---|---|
Enthalten in: |
Journal of histotechnology - 45(2022), 1 vom: 02. März, Seite 36-38 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Vincek, Erik [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarkers, Tumor |
---|
Anmerkungen: |
Date Completed 04.05.2022 Date Revised 04.05.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/01478885.2021.1964872 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329512579 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329512579 | ||
003 | DE-627 | ||
005 | 20231225205258.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/01478885.2021.1964872 |2 doi | |
028 | 5 | 2 | |a pubmed24n1098.xml |
035 | |a (DE-627)NLM329512579 | ||
035 | |a (NLM)34407745 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Vincek, Erik |e verfasserin |4 aut | |
245 | 1 | 0 | |a Melanocytic marker Melan-A detects molluscum contagiosum bodies |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.05.2022 | ||
500 | |a Date Revised 04.05.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Melan-A is one of the most commonly used immunohistochemical assays (IHC) in dermatopathology laboratories to detect the presence and outline the distribution of melanocytes. It is a cytoplasmic stain that detects a melanocyte-specific cytoplasmic protein involved in the formation of stage II melanosomes. Clinically, Melan-A is primarily used to detect and confirm melanocytic tumors although it is also positively expressed in adrenal cortical tumors and sex cord stromal tumors. We found that Melan-A also detected and highlighted Henderson-Patterson bodies of molluscum poxvirus. To determine if other melanocytic markers detect molluscum contagiosum bodies, S-100, HMB-45, MITF, and SOX-10 were also tested. In 15 tested molluscum cases, Melan-A stains were positive in all cases, whereas the other tested melanocytic markers were negative. Our results confirm that Melan-A is very sensitive in detecting molluscum contagiosum bodies and could be clinically useful to supplement the hematoxylin and eosin (H&E) in cases that are very inflamed or only have limited biopsy material | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HMB-45 | |
650 | 4 | |a Henderson–Patterson bodies | |
650 | 4 | |a MART-1 | |
650 | 4 | |a MITF | |
650 | 4 | |a Melan-A | |
650 | 4 | |a S-100 | |
650 | 4 | |a SOX-10 | |
650 | 4 | |a molluscum contagiosum | |
650 | 7 | |a Biomarkers, Tumor |2 NLM | |
650 | 7 | |a MART-1 Antigen |2 NLM | |
650 | 7 | |a Melanoma-Specific Antigens |2 NLM | |
700 | 1 | |a Rudnick, Eric |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of histotechnology |d 1993 |g 45(2022), 1 vom: 02. März, Seite 36-38 |w (DE-627)NLM07979100X |x 2046-0236 |7 nnns |
773 | 1 | 8 | |g volume:45 |g year:2022 |g number:1 |g day:02 |g month:03 |g pages:36-38 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/01478885.2021.1964872 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 45 |j 2022 |e 1 |b 02 |c 03 |h 36-38 |